Prot #AML003: Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination With High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (≥60 Year

Project: Research project

Project Details

StatusActive
Effective start/end date5/1/195/1/22

Funding

  • Novella Clinical, LLC (Prot #AML003)
  • Rafael Pharmaceuticals, Inc. (Prot #AML003)